Clinical Trial 35935

Garden Grove, CA 92845

Study Summary:

To evaluate the efficacy and safety of adjunctive pimavanserin compared with adjunctive placebo in the treatment of schizophrenia

Qualified Participants Must:

• Be 18 years of age and older (Adult, Senior)
• Have a clinical diagnosis of schizophrenia with a minimum duration of 1 year

Qualified Participants May Receive:

Study-related medical care and investigational medication at no cost and may be compensated for time and travel.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.